Stock vs Stock Comparison

Arcturus Therapeutics Holdings Inc. vs Absci Corporation

ABSI wins the Tale of the Tape 6–2.

ARCT$7.60
ABSI$5.94

🏆 Tale of the Tape

26
ARCTABSI
-97.9%Profitability (Net Margin)-4113.7%
-22.1%Efficiency (ROIC)-46.9%
1/9Health (Piotroski F)2/9
0.2Safety (Altman Z)5.1
-51.4%Growth (Rev YoY)-38.2%
0.31Risk (Sharpe 1Y)0.56
0.27xBalance Sheet (D/E)0.14x
-1110.66%FCF Yield-21.57%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.302
252-Day Correlation
0.303
126-Day Correlation

Moderately correlated — some diversification benefit from holding both.

Fundamentals

MetricARCTABSI
Market Cap$0.2B$1.1B
P/E Ratio
Forward P/E-2.0x-10.6x
P/B1.18x6.10x
Dividend Yield
Beta2.422.38

Quantitative Metrics

MetricARCTABSI
DCF Fair Value
DCF Upside
Piotroski F1/92/9
Altman Z0.195.11
Beneish M
FCF Yield-1110.66%-21.57%
Net Debt/EBITDA
ROIC-22.1%-46.9%
WACC
ROIC – WACC
Gross Margin
Net Margin-97.9%-4113.7%
Rev Growth YoY-51.4%-38.2%
Sharpe (1Y)0.310.56
Max Drawdown 3Y-86.7%-66.1%
FCF Payout Ratio

ARCT Price

Loading chart...

ABSI Price

Loading chart...

ETF Exposure

ARCT found in:

VHT0.00%

ABSI found in:

ARKG4.81%
XBI0.32%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ARCT vs ABSI: Head-to-Head Analysis

Arcturus Therapeutics Holdings Inc. (ARCT) and Absci Corporation (ABSI) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABSI leads 6–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ARCT generates a return on invested capital (ROIC) of -22.1% compared to ABSI's -46.9%. This suggests ARCT is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ARCT and ABSI is 0.302, indicating moderate co-movement, with some diversification value from holding both in a portfolio context.

ARCT appears in 1 ETF tracked by SecuritiesDB, while ABSI appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ARCT or ABSI?

Our quantitative analysis compares ARCT and ABSI across nine fundamental dimensions. ABSI wins the Tale of the Tape 6–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ARCT and ABSI correlated?

The 252-day correlation between ARCT and ABSI is 0.302. They show moderate correlation — partially diversifying.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.